Table 4

Diagnostic performance of pleural IL-27, ADA and IFN-γ in in differentiating between patients with tuberculous pleural effusion (TPE) and those with non-TPE in the Wuhan cohort (n=120)

VariableAUC (95% CI)Sensitivity (%)Specificity (%)PLRNLRPPVNPV
IL-27,>591.4 ng/L0.982* (0.939 to 0.998)97.7 (88.0 to 99.9)98.7 (92.9 to 100.0)74.3 (10.6 to 520.8)0 (0 to 0.2)97.7 (88.0 to 99.9)98.7 (92.9 to 100.0)
ADA,>21.4 U/L0.877 (0.805 to 0.930)88.6 (75.4 to 96.2)86.8 (77.1 to 93.5)6.7 (3.7 to 12.1)0.1 (0.1 to 0.3)79.6 (65.5 to 89.8)93.0 (84.3 to 97.7)
IFN-γ,>116.1 ng/L0.953† (0.898 to 0.983)93.2 (81.3 to 98.6)97.4 (90.8 to 99.7)35.4 (9.0 to 139.3)0.1 (0 to 0.2)95.3 (84.0 to 99.5)96.1 (89.0 to 99.2)
IL-27•ADA,
>14 4960.8 ng U/L2
0.943‡ (0.885 to 0.977)88.6 (75.4 to 96.2)100.0 (95.3 to 100.0)0.1 (0.1 to 0.3)100.0 (90.7 to 100.0)93.8 (86.2 to 98.0)
  • *p = 0.006, †p=0.032, 0 p=0.010, compared with ADA using the z statistic, respectively.

  • ADA, adenosine deaminase; AUC, area under the curve; IL-27, interleukin 27; IFN-γ, interferon-γ; IL-27•ADA, the product of IL-27 and ADA; NLR, negative likelihood ratio; NPV, negative predictive value; PLR, positive likelihood ratio; PPV, positive predictive value.